Evidence map›Paper›PMID 32818209›Full record

ArticleResearch square2020

Association Between Antecedent Statin Use and Decreased Mortality in Hospitalized Patients with COVID-19.

Aakriti Gupta, Mahesh V Madhavan, Timothy J Poterucha, Ersilia M DeFilippis, Jessica A Hennessey, Bjorn Redfors, Christina Eckhardt, Behnood Bikdeli, Jonathan Platt, Ani Nalbandian and 19 more

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 47 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 2 institutions in 2 countries.

Aakriti GuptaNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center; Cardiovascular Research Foundation; Yale Center for Outcomes Research and Evaluation.
Mahesh V MadhavanNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center; Cardiovascular Research Foundation.
Timothy J PoteruchaNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center.
Ersilia M DeFilippisNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center.
Jessica A HennesseyNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center.
Bjorn RedforsNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center; Cardiovascular Research Foundation; Sahlgrenska University Hospital.
Christina EckhardtNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center.
Behnood BikdeliNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center; Cardiovascular Research Foundation; Yale Center for Outcomes Research and Evaluation.
Jonathan PlattNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center.
Ani NalbandianNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center.
Pierre EliasNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center.
Matthew J CummingsNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center.
Shayan N NouriNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center.
Matthew LawlorNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center.
Lauren S RanardNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center.
Jianhua LiNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center.
Claudia BoyleNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center.
Raymond GivensNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center.
Daniel BrodieNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center.
Harlan M KrumholzYale Center for Outcomes Research and Evaluation.
Gregg W StoneCardiovascular Research Foundation.
Sanjum S SethiNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center.
Daniel BurkhoffNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center; Cardiovascular Research Foundation.
Nir UrielNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center.
Allan SchwartzNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center.
Martin B LeonNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center; Cardiovascular Research Foundation.
Ajay J KirtaneNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center; Cardiovascular Research Foundation.
Elaine Y WanNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center.
Sahil A ParikhNewYork-Presbyterian Hospital and the Columbia University Irving Medical Center; Cardiovascular Research Foundation.
NewYork–Presbyterian Hospital · USCardiovascular Research Foundation · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
POSTDOCTORAL TRAINING IN CARDIOVASCULAR DISEASET32HL007854 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Marwah Abdalla, Michael Argenziano · 1996 to 2026
$14.7M
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS T32 HL007854
6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can result in a hyperinflammatory state, leading to acute respiratory distress syndrome (ARDS), myocardial injury, and thrombotic complications, among other sequelae. Statins, which are known to have anti-inflammatory and antithrombotic properties, have been studied in the setting of other viral infections and ARDS, but their benefit has not been assessed in COVID-19. Thus, we sought to determine whether antecedent statin use is associated with lower in-hospital mortality in patients hospitalized for COVID-19. This is a retrospective analysis of patients admitted with COVID-19 from February 1

Identifiers

PMID32818209
PMCPMC7430584
OpenAlexW3080168003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.